Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . December 30th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Viral Hepatitis - Nitric oxide synthase a contributor to hepatitis pathology
Hepatitis B Detection - New test quickly identifies both surface and e antigen of hepatitis B
Assisted Reproduction - Risk for hepatitis C virus in semen presents need for laboratory caution
Chronic Hepatitis B - Interferon enhances long-term lamivudine use for hepatitis B virus
Hepatitis B Risk Factors - Lamivudine prophylaxis disables chemotherapy-related viral reactivation
Pediatrics - Histologic activity of childhood chronic hepatitis B studied
Zoonosis - Rodents could be reservoir for hepatitis E virus transmissions
AIDS Therapy - ViroLogic signs preferred provider agreement and equity agreement
Cell Biology - HCV core protein interferes with protein transport to nucleus
Disease Associations - Study finds higher HCV seropositivity in patients with age-related cataract
Disease Prevention - Bleach-disinfected syringes may help protect injecting drug users against HCV
Disease Progression - Long-term follow-up conducted of chronic hepatitis C in Japan
Disease Transmission - Erosive vulvar lichen planus may contribute to intrapartner spread of HCV
Epidemiology - Distribution of HCV genotype and HGV coinfection rate in Saudi Arabia reported
Epidemiology - Genetic analysis conducted of HCV transmission among injection drug users
Epidemiology - WHO reports on model of hepatitis C virus infection in the U.S.
Facilities - Drug discovery labs expanded
Finance - Viral-disease focused biotech releases third quarter 2002 financial results
Financing - Viral-disease focused biotech announces $7.0 million private placement
HBV Virology - Murine model of acute hepatitis B virus infection developed
Hepatitis C Therapy - New data shows ISIS 14803 produces significant viral level reductions
Hepatocellular Carcinoma - IFN therapy doesn't prevent liver cancer in HCV-compensated cirrhosis
Interferon Therapy - High-intensity regimen for chronic HCV genotype lb infection not well tolerated
Interferon Therapy - Human serum albumin-interferon-alpha fusion protein studied
Legal Issues - SEC charges settled
Liver Transplantation - Cardiovascular disease risk factors decline after liver implantation
Pathology - Role of hepatitis B virus X protein in infection elucidated
Pediatrics - Immune deficiency in Nijmegen breakage syndrome is variable, progressive
Preparedness - Patient violence greatest threat to ED workers; EDs unready for bioterrorism
TT Virus - Researchers use phylogenetics to study virus' evolution
Virology - Study reports high HIV, HCV rates among African-, Latino-American drug injectors
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
